Monoclonal Antibodies

IRON CONTROL | Disc Medicine And Mabwell Sign Deal For Licence To Antibodies Portfolio

Disc plans to initiate a phase 1 trial in healthy volunteers in the second half of 2023. MWTX-003 has the potential to address a wide range of hematologic disorders including…